*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Sitagliptin Intermediates Impurity refers to process-related byproducts or degradation products in the synthesis of <strong>Sitagliptin phosphate</strong>. These compounds are critical for quality control and method development. The primary intermediate is typically <strong>N-((4-methoxyphenyl)sulfonyl)-2,6-dioxo-3-piperidinyl)acetamide</strong>, with CAS No. 157807-59-5.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing</strong>: Used as reference standards for HPLC purity testing during API production.</li>
<li><strong>R&D Laboratories</strong>: Employed in stability studies to identify degradation pathways under stress conditions.</li>
<li><strong>Regulatory Compliance</strong>: Essential for submitting impurity profiles to FDA and EMA for drug approval.</li>
</ul>
<h3>Precautions</h3>
<ul>
<li><strong>Storage</strong>: Keep in a cool, dry place below 25°C away from direct sunlight.</li>
<li><strong>PPE</strong>: Wear gloves and safety goggles; avoid inhalation of dust.</li>
<li><strong>Usage</strong>: For research use only; not intended for clinical administration.</li>
</ul>